VTGN offering history
Every offering-related filing in Vistagen Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 902 filings back to Sep 11, 2007.
| Date | Filing | What it means | |
|---|---|---|---|
| Jun 17, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 29, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 13, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 3, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 8, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 30, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 21, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 17, 2023 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Mar 2, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 2, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 14, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 26, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 15, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 21, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 18, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Dec 17, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 4, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 31, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 15, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 13, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 11, 2020 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| May 1, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 15, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 14, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 10, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 31, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Mar 26, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 27, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 24, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 8, 2019 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 7, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 4, 2019 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Sep 30, 2019 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 27, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 25, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 26, 2018 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 13, 2018 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 9, 2018 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 12, 2017 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Dec 11, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
VTGN offering FAQ
When did VTGN last execute an offering?
Per SEC filings, Vistagen Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2025-06-17. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did VTGN last announce or register an offering?
The most recent registration is a S-3 filed 2024-02-13. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.